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Abstract
Several genome-wide association and candidate gene studies have linked chromosome 15q24–q25.1 (a region including
the CHRNA5-CHRNA3-CHRNB4 gene cluster) with alcohol dependence, nicotine dependence and smoking-related illnesses
such as lung cancer and chronic obstructive pulmonary disease. To further examine the impact of these genes on the
development of substance use disorders, we tested whether variants within and flanking the CHRNA5-CHRNA3-CHRNB4
gene cluster affect the transition to daily smoking (individuals who smoked cigarettes 4 or more days per week) in a cross
sectional sample of adolescents and young adults from the COGA (Collaborative Study of the Genetics of Alcoholism)
families. Subjects were recruited from families affected with alcoholism (either as a first or second degree relative) and the
comparison families. Participants completed the SSAGA interview, a comprehensive assessment of alcohol and other
substance use and related behaviors. Using the Quantitative trait disequilibrium test (QTDT) significant association was
detected between age at onset of daily smoking and variants located upstream of CHRNB4. Multivariate analysis using a Cox
proportional hazards model further revealed that these variants significantly predict the age at onset of habitual smoking
among daily smokers. These variants were not in high linkage disequilibrium (0.28,r
2,0.56) with variants that have
previously been reported to affect risk for nicotine dependence and smoking related diseases in adults. The data suggests
that an age-associated relationship underlies the association of SNPs in CHRNB4 with onset of chronic smoking behaviors in
adolescents and young adults and may improve genetic information that will lead to better prevention and intervention for
substance use disorders among adolescents and young adults.
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Introduction
Cigarette smoking is a common addictive disorder. A recent
Surgeon General’s report indicates that one-third of people who
have tried smoking become daily smokers [1]. In 2009, an
estimated 20.6% (46.6 million) of Americans aged 18 years or
older were current smokers (defined as those who reported that
they smoked 100 cigarettes or more during their lifetime and
currently smoke every day or some days [2]). Although
antismoking campaigns have reduced cigarette use in recent
years, the long-term decline of smoking came to a halt in 2010,
especially among high school students. In 2010, both 8th and 10th
graders showed evidence of an increase in smoking and
approximately one in five high school students and adults in the
United States continue to smoke regularly [1].
It is well established that the use of tobacco products or
exposure to second-hand smoke has detrimental effects on physical
health including an increased risk of heart disease, cancer, stroke,
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33513and chronic lung disease. In the United States, cigarette smoking
accounts for 30% of all cancer deaths and for nearly 80% of deaths
from chronic obstructive pulmonary disease [2,3]. It is also the
primary causal factor for early cardiovascular disease and deaths
[2].
Many aspects of cigarette smoking behavior, including onset of
smoking, smoking persistence, and nicotine dependence, cluster in
families [4]. In addition to environmental factors (such as peer
pressure), evidence from twin studies indicates that genetic factors
contribute to the development of smoking and related addictive
behaviors with heritability estimates ranging from 60% to 72% [5–
7]. Genome wide association studies (GWAS) and candidate gene
studies of nicotine dependence have identified several variants in
the gene cluster encoding the a5, a3, and b4 nicotinic receptor
subunits on chromosome 15 that alter risk for nicotine
dependence, including an amino acid substitution (aspartic acid
to asparagine at codon 398) in the a5 nicotinic receptor subunit
gene (CHRNA5) and several non-coding variants [8–15]. GWAS
using several lung cancer populations have also demonstrated
association between lung cancer susceptibility and the same or
highly correlated variants in the CHRNA5-CHRNA3-CHRNB4
gene cluster [16–18].
The association of genetic risk factors with nicotine dependence
may be influenced by characteristics of smoking behavior such as
the number of quit attempts, smoking frequency in adolescents,
and age at onset (AAO) of daily smoking [19,20]. A study using
haplotype analysis with variants in the CHRNA5-CHRNA3-
CHRNB4 gene cluster reported that variation in this cluster is
associated with severity of nicotine dependence among long-term
smokers who began daily smoking at age 16 or younger. Notably,
this association was not present among those who began daily
smoking after age 16 [21]. To further examine the impact of this
gene cluster on the development of nicotine use, we tested whether
variants within and flanking the CHRNA5-CHRNA3-CHRNB4
gene cluster affect AAO of daily smoking in a sample of
adolescents and young adults from the COGA (Collaborative
Study of the Genetics of Alcoholism) families.
Materials and Methods
Study subjects
The Human Studies Committee at the Washington University
School of Medicine in Saint Louis approved the study. Approval
number for our Collaborative Study on Genetics of Alcoholism:
Molecular Biology of Alcoholism is 04-0057. A written informed
consent was reviewed and obtained from family members.
The dataset included in this study is a cross sectional sample of
the COGA subjects who have had at least one assessment between
the years 1989–2008 when they were between the ages of 12 and
25 years. Subjects were recruited from families affected with
alcoholism (either as a first or second degree relative) and the
comparison families in COGA. The assessment used SSAGA
interviews (versions I through 4 and CSSAGA) comprehensive
assessments of alcohol and other substance use and related
behaviors [22,23]. The sample consists of 693 families with size
ranging from 4–27 (avg. 4.82) and 374 individuals without siblings.
Juvenile Diagnoses. All outcome variables related to
cigarette use are lifetime measures constructed from each
individual’s sequential set of direct interviews. The criteria for
each of the ever/never measures were examined on each of the
interviews in turn and were assessed independently of any other
interview(s). Once the criteria for a given measure were met, the
variable was coded as present (even if the criteria were not met on
a subsequent assessment). The corresponding AAO variable was
set to the age reported on and/or computed from the interview on
which the subject first met criteria for the lifetime measure.
Parental Diagnoses. Parental diagnoses were constructed
from each parent’s structured set of assessments. This set of
assessments consisted of all available direct interviews. However, if
there were no direct interviews available, then the sequential set of
family-history assessments specific to that parent were substituted.
The criteria for each of the ever/never measures were examined
on each of the assessments in turn, independently of any other
assessment. Once the criteria for a given measure were met, then
variable was coded as present and the corresponding AAO
variable was set to the age reported.
Smoking measures
Daily smokers are individuals who smoked cigarettes 4 or more
days per week. Age at onset for daily smoking was the AAO from
the first interview in which the subject reported daily smoking.
Habitual smokers are individuals who smoked at least one pack a
day for 6 months or more. Non-habitual smokers are individuals
who smoked more than 100 cigarettes lifetime but did not meet
the criteria for habitual smoking. Sample characteristics are shown
in Table 1.
Specific SNPs/genes tested
We hypothesized that variants within and flanking the
CHRNA5-CHRNA3-CHRNB4 gene cluster on chromosome
15q24–25.1 region that were associated with nicotine dependence
and smoking related phenotypes may also affect AAO of daily/
habitual smoking. We tested 10 SNPs (single nucleotide polymor-
phisms; Table 2) in this gene cluster that tagged variants associated
with nicotine dependence and smoking related phenotypes [9,10].
Genotyping was performed at the Genome Technology Access
Center at Washington University School of Medicine in St. Louis
(http://gtac.wustl.edu/) using an Illumina GoldenGate custom
array as part of a larger set of 384 SNPs.
Data analysis
Association analyses with age at onset of daily smoking in daily
smokers were conducted using the statistical software QTDT
(Version 2.4.5, http: sph.umich.edu/csg/abecasis/QTDT; [24]).
Among daily smokers both total and within-family (orthogonal
model) evidence for association was assessed using age at onset of
daily smoking as a continuous variable. The orthogonal model is
the generalization of the Fulker model [24], allowing for families of
any size (with or without parental genotypes) and was used in a
variance components framework. QTDT total association test
evaluates total evidence for association and is more powerful than
QTDT orthogonal test in absence of population stratification.
Therefore we first evaluated the evidence of population stratifi-
cation by comparing the between and within components of
association using QTDT stratification test.
The age at onset for habitual smoking among daily smokers was
analyzed using Cox proportional hazards regression analysis
(coxph) using the R statistical analysis package. This analysis can
incorporate a clustered sandwich estimator to account for the
familial correlation among observations. The age at onset
measures for non-daily smokers were right-censored at each
subject’s age at their most recent assessment. The first principal
component from the stratification analysis (pc1), age at interview,
gender, maternal/paternal daily smoking and maternal/paternal
regular drinking were included as covariates. The violation of the
proportional hazards assumption was tested with non-zero slope of
Schoenfeld residuals versus time using the survival analysis
package in R.
SNPs Near CHRNB4 Affect Age at Onset of Smoking
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coding SNP, rs16969968 in CHRNA5, increases the risk for
nicotine dependence [8–15]. To test whether rs16969968
underlies the association between variants upstream of CHRNB4
and AAO of daily smoking, we included rs16969968 as a covariate
in QTDT and survival analysis.
Results
Variants located upstream of CHRNB4 are significantly
associated with age at onset of daily smoking using
QTDT analysis
In this data set, QTDT finds no evidence for stratification
therefore we performed QTDT-total test to evaluate the total
evidence for association. Several SNPs show significant associa-
tion with AAO of daily smoking (Table 2). The most significantly
associated variant is rs1996371, located upstream of the CHRNB4
gene (p=0.002). Individuals homozygous for the risk allele had
AAO at least one year earlier than individuals who are
homozygous for the non-risk allele; the difference in AAO
between these two groups was statistically significant (p=0.0002;
Table 3). Variants rs11634351 and rs922692 that are highly
correlated with rs1996371 (r2=0.98 and r2=0.95, respectively)
also show association with AAO of daily smoking. Conditional
analysis showed that association of rs1996371 and correlated
SNPs with AAO of daily smoking is independent of rs16969968
(Table 2). Conditional analysis using variants rs578776 and
rs880395, which represent other distinct loci in this gene cluster
produced similar results and confirmed the independent rela-
tionship of rs1996371 (p,0.005). Variants rs1996371 and
rs922692 withstood the conservative Bonferroni correction
(,0.005). Because most of the markers used in this study are
highly correlated we also performed the less conservative
correction of SNPs in LD with each other given by Nyholt et
al [25]. This method provides the effective number of
independent marker loci and in the present study this number
was 5, giving an experiment-wide significance threshold of
p,0.01. According to this less stringent criterion for correction,
rs1996371, rs11634351, and rs922692 were significant after
correction for multiple testing.
Variant rs1996371 and highly correlated SNPs affect age
at onset among daily smokers using survival analysis
We further explored the effects of rs1996371 on smoking
behaviors by testing whether this SNP modifies the AAO of
habitual smoking among subjects who are already daily smokers.
For non-habitual smokers, the AAO measures were right-censored
at each subject’s age at their most recent assessment. Our Cox-
Table 1. Characteristics of study subjects who are daily smokers.
All Daily Smokers Habitual Smokers Non-Habitual Smokers
Number of subjects (% Males) 1312 (53.04) 384 (57.81) 889 (51.29)
European Americans (% Males) 951 (49.94) 324 (55.55) 597 (47.23)
African Americans (% Males) 234 (62.39) 27 (62.96) 201 (62.68)
Unknown ethnicity (% Males) 127 (59.05) 33 (75.75) 91 (52.74)
Mean age at interview (years) 22.0463.9 23.6664.26* 21.3863.44*
Age range at interview (years) 13–38 15–38 14–34
Mean age at onset (years) 16.1862.62 15.7362.93 NA
Age range of onset (years) 8–28 8–29 NA
*Indicates t test (two tailed) p=0.0001.
doi:10.1371/journal.pone.0033513.t001
Table 2. QTDT analysis with age at onset of daily smoking as quantitative variable.
QTDT Total
1 QTDT Orthogonal
1
SNP N without rs16969968
2 with rs16969968
2 N without rs16969968
2 with rs16969968
2
rs880395 1288 0.02 0.02 212 0.08 0.08
rs7164030 1289 0.02 0.02 214 0.08 0.08
rs16969968 1288 0.25 - 174 0.52 -
rs578776 1289 0.17 0.18 218 0.66 0.66
rs3743078 1289 0.17 0.19 192 0.14 0.13
rs11634351 1289 0.007 0.006 188 0.03 0.04
rs17487514 1288 0.007 0.006 146 0.004 0.005
rs1996371 1288 0.003 0.002 186 0.02 0.03
rs11857532 1287 0.02 0.02 245 0.02 0.02
rs922692 1288 0.003 0.003 183 0.02 0.03
1Age at interview in quartiles, gender, first principal component of stratification (pc1), parental smoking and parental drinking were included as covariates.
2Nominal P values are shown uncorrected for multiple testing. The Bonferroni-corrected significance threshold is P=0.005.
doi:10.1371/journal.pone.0033513.t002
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non-habitual smokers demonstrated that the individuals who have
a minor allele of rs1996371 and highly correlated variants have 1.2
times more chance of becoming habitual smokers with every one-
year increase in their age (Table 4). We tested the proportional
hazard assumption for all covariates using Schoenfeld residuals
and no violation was detected. The strongest effect of association
with rs1996371 is between 14 and 21 years (Figure 1). At age 21,
43% of individuals with 2 copies of the minor allele of rs1996371
are habitual smokers while 25% of individuals homozygous for the
major allele are habitual smokers (Figure 1). We also performed
the same analysis using rs16969968 as a covariate and confirmed
that the effect of rs1996371 and correlated variants on AAO of
habitual smoking is independent of the influence of rs16969968
(Table 4). The effect remained significant after controlling for
other variants in this gene cluster (HR. 1.23, P,0.005) and
Bonferroni correction for multiple testing. Some earlier studies
showed that gender is a major factor influencing smoking
behaviors. In our stratified analysis, although power was reduced,
rs1996371 and correlated SNPs significantly predicted risk for
habitual smoking with increasing age in females and males
(females: rs1996371, p=0.05, HR: 1.25; males: rs1996371,
p=0.02, HR:1.2).
Discussion
People who start smoking at a young age are more likely to
have higher lifetime amounts of tobacco smoked and conse-
quently are at greater risk of becoming nicotine dependent [19].
Variants flanking and within the CHRNA5-CHRNA3-CHRNB4
gene cluster region affect the risk for nicotine dependence [8–
15], and are also involved in the transition toward heavy
smoking in mid-adulthood and in smoking persistence [26].
Studies using haplotype analysis reported that common haplo-
types in this gene cluster are associated with nicotine dependence
in adults especially among those who began daily smoking before
age 16 [21]. These haplotypes also linked to nicotine withdrawal
and smoking cessation phenotypes though the associations were
not influenced by AAO of daily smoking [27]. In this study, we
conducted family-based association tests using AAO of daily
smoking as a quantitative phenotype. We identified an
association between AAO of daily smoking and a group of
correlated variants located upstream of CHRNB4 gene in a
cohort of young adults, that was independent of the effect of
rs16969968.
There are many environmental factors such as influence of
peer group [28], lack of parental monitoring [29] and easy
access to cigarettes can also influence the genetic liability to
smoking behavior in young adults. Koopmans et al [30]
reported that the total variance accounted by genetic influences
on smoking initiation and cigarettes per day is 39% and 86%,
respectively. The liability to ever smoking is largely independent
f r o ml i a b i l i t yt oc o n t i n u et os m o k e .T h i sc o u l db ed u et ot h ef a c t
that while over 80% of individuals in some studies report that
they have tried smoking cigarettes, only about one third of them
will smoke beyond experimentation [31]. Hence genetic factors
may have stronger impact on daily smoking (smoked $4d a y s /
week) and habitual smoking (one pack a day for 6 months)
rather than smoking initiation. Therefore in the present study
we focused on subjects ascertained as daily smokers to find out
the relationship between CHRNA5-CHRNA3-CHRNB4 variants
and onset of daily/habitual smoking behaviors, believing that
this selected group can explain more genetic variance than
smoking initiation or exposure. We found that the rs1996371
and correlated variants located upstream of CHRNB4 gene were
associated with age at onset of daily smoking. Since our sample
is multi-ethnic we also restricted our analyses to the largest
subgroup (European Americans) to ensure that the association
Table 3. Distribution of age at onset of daily smokers with reference to alleles of rs1996371.
Genotype Daily Smoker Habitual Smoker Non-Habitual Smoker
Mean age at onset (N) Mean age at onset (N) Mean age censored (N)
AA 16.4162.6 (611)* 15.6763.09 (147) 21.5463.45 (465)
AG 16.0762.6 (518) 15.8262.92 (173) 21.1563.40 (330)
GG 15.5662.4 (162)* 15.5562.59 (64) 21.4263.48 (94)
*Indicates t test (two tailed) p=0.0002.
doi:10.1371/journal.pone.0033513.t003
Table 4. Cox-proportional hazard analysis using age at onset of habitual smoking censored at non-habitual smokers.
without rs16969968 as a covariate
1 with rs16969968 as a covariate
1
Marker N Hazard ratio (95%CI) p value
2 N Hazard ratio (95%CI) p value
2
rs11634351 1273 1.23 (1.07–1.43) 0.005 1288 1.23 (1.05–1.44) 0.008
rs17487514 1273 1.14 (0.97–1.34) 0.11 1288 1.13 (0.95–1.35) 0.15
rs1996371 1272 1.24 (1.07–1.43) 0.004 1288 1.23 (1.05–1.44) 0.008
rs11857532 1271 1.14 (0.99–1.32) 0.05 1288 1.14 (0.98–1.32) 0.09
rs922692 1272 1.24 (1.07–1.43) 0.004 1288 1.23 (1.06–1.44) 0.008
1Analysis was performed within family clusters using additive model. Age at interview in quartiles, gender, pc1, parental smoking and parental drinking were included as
covariates.
2Nominal P values are shown uncorrected for multiple testing. The Bonferroni-corrected significance threshold is P=0.005.
doi:10.1371/journal.pone.0033513.t004
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association remained in this subgroup. The association between
age at onset of daily smoking and rs1996371 and correlated
SNPs also remained statistically significant after correcting for
multiple testing proposed by Nyholt et al [25], (rs1996371,
p=0.0058). The daily smokers who had at least one copy of the
minor allele of rs1996371 had a mean AAO of daily smoking 1
year younger than individuals without the minor allele. The
non-synonymous SNP, rs16969968 was not associated with age
at onset of daily smoking. We further wanted to explore whether
daily smokers with these variants are at increased risk of
becoming habitual smokers in future. Our Cox-proportional
hazard analysis indeed showed that smokers who have an early
AAO of daily smoking and carry a minor allele of rs1996371
have approximately 1.2 times higher risk of becoming habitual
smokers compared to daily smokers who carry the major allele.
This association was further confirmed in stratified analysis in
EAs (rs1996371, p=0.03, HR: 1.17). In African Americans the
variant was not statistically significant, most likely because of
low power, but the effect was in the same direction (rs1996371,
p.0.05, HR: 1.21). SNP rs1996371 has low correlation
(0.28,r
2,0.56 in Europeans using HapMap data, Figure 2)
with variants (e.g. rs1051730, rs16969968) that were reported to
affect risk for nicotine dependence and smoking related diseases
in adults. Interestingly Schlaepfer et al reported a variant in the
39UTR of CHRNB4 gene, rs1948, has been linked to early age
of initiation for tobacco use in an ethnically diverse young adult
cohort [32]. They also found that a variant, rs11634351 that is
in low LD with rs1948 (r2=0.24) had significant association
with age at first drink [32]. In current study we found that
rs11634351 is associated with AAO of daily smoking and is in
complete LD with rs1996371 (Figure 2). High comorbidity
among smoking and drinking behaviors might explain this
possible overlap [33].
The most significant variant in this study (rs1996371) was also
found to be associated with CHRNB4 mRNA expression in human
brain (p=0.01) [34]. There are a few functional studies that have
reported the possible involvement of the CHRNB4 gene with drugs
of abuse. Bruschweiler-Li et al. demonstrated that a 2.3-kb
fragment of the CHRNB4 promoter region containing the CA box
is capable of directing cell-type specific and developmentally
regulated expression of a reporter gene in vivo [35]. There is also
some indication that blockade of a3b4 nAChRs results in a
reduction of opioid and stimulant self-administration, suggesting
that nAChRs that contain the b4 subunit are involved in
mediating withdrawal syndromes elicited by some drugs of abuse
[36]. In a study using transgenic mice, Frahm and colleagues [37]
showed that targeted overexpression of b4 leads to strong aversion
to nicotine. This study further provided evidence that the medial
habenula acts as a gate-keeper in the control of nicotine
consumption and that the balanced contribution of b4 and a5
subunits is critical for this function. Thus, further studies
elucidating the molecular mechanisms underlying expression of
the b4 gene may improve our understanding of nicotine addiction
and withdrawal as well as lung cancer, and other smoking-related
diseases.
In this study we identified distinct variants in the CHRNA5-
CHRNA3-CHRNB4 gene cluster that influence the age at onset of
habitual smoking in young adults. These variants are not in LD
with rs16969968 or its correlates that are associated with nicotine
dependence. Earlier Schlaepfer and coworkers [32] also showed
that variants other than rs16969968 or its correlates affect age at
initiation of tobacco use at early age. These results show that there
may be different mechanisms, which promote smoking behaviors
at younger ages. The age dependent interplay of nicotinic
receptors subtypes could explain the process of initiation to
persistence of chronic smoking behaviors, but there remains a
need for follow-up studies to confirm the hypothesis.
Figure 1. Genotypes of rs1996371 significantly predict age at onset of habitual smoking.
doi:10.1371/journal.pone.0033513.g001
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